Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000192864 | SCV000168555 | likely benign | not specified | 2018-02-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000192864 | SCV000247378 | uncertain significance | not specified | 2014-07-08 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000192864 | SCV000335985 | likely benign | not specified | 2015-10-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000456138 | SCV000559439 | likely benign | Walker-Warburg congenital muscular dystrophy | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001093246 | SCV000613306 | uncertain significance | not provided | 2020-02-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001093246 | SCV001250137 | uncertain significance | not provided | 2019-12-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001093246 | SCV002048979 | uncertain significance | not provided | 2023-10-20 | criteria provided, single submitter | clinical testing | The FKRP c.1177G>A; p.Val393Ile variant (rs140679502), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 137380). This variant is found in the African population with an allele frequency of 0.7% (162/24462 alleles, including 1 homozygote) in the Genome Aggregation Database. The valine at codon 393 is highly conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.66). Due to limited information, the clinical significance of the p.Val393Ile variant is uncertain at this time. Gene specific statement: Pathogenic variants in FKRP are inherited in an autosomal recessive manner and are associated with muscular dystrophy-dystroglycanopathy types A5, B5 and C5 (MIM: 613153, 606612, and 607155). Symptomatic heterozygous carriers have also been reported at least once in the literature and present with a milder phenotype (Schottlaender et al. 2015). |
Ambry Genetics | RCV002336274 | SCV002639713 | benign | Cardiovascular phenotype | 2019-01-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Duke University Health System Sequencing Clinic, |
RCV001275320 | SCV003919050 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2023-04-20 | criteria provided, single submitter | research | |
Mayo Clinic Laboratories, |
RCV001093246 | SCV004225417 | uncertain significance | not provided | 2023-04-18 | criteria provided, single submitter | clinical testing | BS1 |
Natera, |
RCV001275320 | SCV001460345 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2020-01-10 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004530080 | SCV004750943 | likely benign | FKRP-related disorder | 2019-06-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |